HJ

Hardeepsinh Jitendrasinh Gohel

Active Director Designated Partner DIN 10996518
DIN 10996518 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hardeepsinh Jitendrasinh Gohel

Data last updated:

Hardeepsinh Jitendrasinh Gohel is a Designated Partner at Vibhuti Lifesciences Llp (since 2025). The company operates in Pharma.

DIN 10996518
Primary Designation Designated Partner
Industry Pharma
First Appointment 11 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Mar 20252025Active

Board colleagues of Hardeepsinh Jitendrasinh Gohel

NameDINCompanyDesignation
Ravina Janakray Vekariya10886270Vibhuti Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vibhuti Lifesciences Llp
Premium access

Shareholding and investment profile for Hardeepsinh Jitendrasinh Gohel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hardeepsinh Jitendrasinh Gohel

Hardeepsinh Jitendrasinh Gohel currently holds 1 directorship: Vibhuti Lifesciences Llp (Designated Partner, since 11 Mar 2025).

Hardeepsinh Jitendrasinh Gohel was first appointed on 11 Mar 2025 as Designated Partner at Vibhuti Lifesciences Llp.

The current boards of Hardeepsinh Jitendrasinh Gohel's companies include Ravina Janakray Vekariya (Vibhuti Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available